Infected Blood Inquiry

Clive Efford Excerpts

Friday 26th July 2024 Commons Chamber

[Nick Thomas-Symonds]

I am very grateful to the right hon. Gentleman for the characteristically collegiate way in which he approached his perfectly reasonable questions. I shall deal with them one by one.

I will certainly push for the debate to be scheduled as soon as possible. It is really important that across the House we are able to comprehensively consider not just the recommendations, but the level and scale of the criticisms that have been made. Yes, the Government will respond one by one to the 12 recommendations made by Sir Brian Langstaff. In relation to Sir Robert Francis, I entirely agree with the right hon. Gentleman about the need for transparency. I certainly undertake to publish those findings and that report ahead of the regulation to operationalise the scheme being laid by 24 August.

In relation to the right hon. Member’s point about the 90 days, my understanding is that the payments were completed on 24 June, which is within that 90-day period, but there will be, as I announced in my statement, additional interim payments to the estates of infected people and that process will begin from October.

With regard to parliamentary scrutiny, I welcome the scrutiny that there rightly will be on this, whether it is by PACAC or, indeed, by the House more generally. I certainly undertake, as the right hon. Gentleman did, to ensure that all relevant information is provided to the prosecuting authorities as they see fit for any action that needs to be taken against specific individuals.

Finally, in respect of memorialisation, Sir Brian Langstaff set out that there should be memorials in the constituent parts of the United Kingdom, and also a specific memorial to those children who were sent to Treloar’s for protection, but who ended up in the hideous situation of being experimented on when they were at their most vulnerable. I look forward to taking forward the process, as the right hon. Gentleman committed to do, of ensuring that we do have appropriate memorialisation, which is crucial to recognising the scale of what happened.

[Clive Efford (Eltham and Chislehurst) (Lab)]

May I congratulate you, Madam Deputy Speaker, on your elevation to your position?

I welcome the Minister’s statement this morning, but can he say a little more about how the compensation authority will arrive at its decisions? There is concern that advisers have undue influence on the Cabinet Office and that the voices of those who have been infected and affected are not being heard sufficiently in this process. There are concerns about the compensation process and whether that will be in addition to, or conflated with, support payments; the non-payment of exemplary or punitive damages; the lack of recognition of the impact of illegal experimentation or the knowing use of contaminated blood products; and the payments that will be made to estates where people have died. The people who really should be scrutinising this are those who have been infected and affected, so will the Minister commit to involving them in the compensation authority, so that they can have confidence in the decisions that are being made?

[Nick Thomas-Symonds]

I am grateful to my hon. Friend for his questions. First, may I say that, of course, the voice of victims should be absolutely central to this. I thank Sir Robert Francis for the work that he did in the general election purdah period to ensure that that is the case. I will consider very carefully the recommendations that Sir Robert makes on the basis of that engagement and hearing the voice of the victims.

I want to deal with one other point that my hon. Friend raised, which was to do with the future of the infected blood support schemes. I understand that there has been concern about this. The current proposal is that no immediate changes will be made to the infected blood support schemes. Payments will continue to be made at the same level until 31 March next year, and they will not be deducted from any compensation awards.

From 1 April next year, people who receive the England infected blood support scheme payments will continue to receive them until such time that their case is assessed under the new scheme by the Infected Blood Compensation Authority. Once assessed under the scheme, the applicant will be able to choose how to receive their compensation, either as a lump-sum or periodic payment. I hope that that gives my hon. Friend the reassurance he seeks.

I have absolute confidence in Sir Robert Francis to run the Infected Blood Compensation Authority in an entirely appropriate way. I was in the Chamber when his appointment as the interim chair was announced, and it was welcomed warmly, as I recall, from the Public Gallery by the infected blood community.